曲马多引起胚胎发育缺陷的分子机制
[Abstract]:Drug abuse in maternal pregnancy is one of the most important factors for abortion. Tramadol is a widely used analgesic, which has the multiple effects of analgesia, appetite suppression and depression. Currently, the tendency of tramadol addiction and abuse is becoming more and more young. It is reported that more and more addicts are between 18-30 years of age and this age stage is positive. It is a woman's childbearing age. Clinical studies have shown that tramadol exposure during pregnancy greatly increases the abortion rate of women, but the specific mechanism is not clear. The relationship between craniofacial and neural crest development suggests that tramadol may interfere with the development of embryonic neural crest caused by embryonic defects. This topic further explores the effect of tramadol on the neural crest induction and migration, and studies the related molecular mechanisms. The results will be responsible for understanding the causes of the drug addiction and the causes of teratogenicity. It is of great practical significance and scientific value to evaluate the potential risk of this kind of drug in clinical application. Method first, the claw frog embryo in the cleavage stage was exposed to different concentrations of MBS culture containing tramadol (1:200,1:400,1:500). The whole process of embryo development was continuously observed under the Olympus anatomy microscope, and the embryo malformation was found. The drug concentration, and the experiment group and the control group of embryos were photographed under the stereoscopic microscope. The skull cartilage of the embryo (45 period) was stained with octyl blue, the development of the craniofacial cartilage was observed and photographed under the stereoscopic microscope. The objective evaluation of the effect of tramadol on the development of embryo was to find the drug concentration of the abnormal embryo. The concentration of tramadol in the embryo was measured by liquid chromatography and compared with the blood concentration of tramadol in human. The embryos were exposed to different concentrations of tramadol containing MBS culture. The embryos were cultured to the nerve plate period (14-15 phase) and the tail (25 phase). At this time the embryo had been induced and started to migrate, collect the embryo and construct the nerve. The related gene probes (Foxd3, N-tubulin, Sox2, Slug, Twist) induced by crest cells were used to detect the related transcriptional gene expression of Wnt, Fgf, BMP, and Notch/Delta in the embryonic neural plate and the tail teeth by in situ hybridization, and to investigate whether tramadol affects the neural crest induction and migration. In vitro experiments, U251 cells are used in the experiment. Transwell test was used to examine the effect of tramadol on cell migration in vitro and whether it was consistent with the response in the embryo. TUNEL was used to detect the apoptosis of fetal cells under tramadol exposure. The 17 stages of neural crest were stripped and Q-PCR was used to detect the expression of related adhesion molecules affecting the beginning of the migration of the neural crest. The difference between the control groups. Results (1) the early embryos were exposed to tramadol after exposure to abnormal cytochrome development, small embryo volume, small head and a series of developmental defects. (2) the development defects caused by tramadol exposure in early embryos were mainly caused by the inhibition of the migration of neural crest. (3) after tramadol exposure, cadherin adhered to adherence The confusion of molecular expression may be the cause of the disturbance of the neural crest migration. Conclusion the early embryo tramadol exposure is mainly caused by disturbance of the migration of the embryonic neural crest. The interference of tramadol on the neural crest development may be caused by the expression of the adhesion molecules interfering with the calcicin dependence. The clinical observation of tramadol Atopic dermatitis AD is one of the most common pruritus in Department of dermatology. The incidence of atopic dermatitis (atopic) is one of the most common pruritus in Department of dermatology. Its incidence is close to 20%. This disease is mainly pruritus. Clinical manifestations, easy to relapse, not easy to cure, patients often accompanied with anxiety, depression and other psychological disorders, negative emotions can cause neurotransmitter release, the impact of the HPA axis, and ultimately affect the phenotype of Th cells, the skin barrier function damage, itching tolerance, mental illness, worsening sleep disorders, the formation of a vicious cycle, clinical commonly used anti group Amines have only part of the clinical efficacy of AD in alleviating pruritus. Combined with our domestic and foreign research reports and our research basis, it is recognized that fluoxetine as a 5-HT reuptake inhibitor can relieve mental symptoms such as anxiety and depression. In addition, it can regulate the effects of lymphocyte proliferation on inflammatory dermatosis and can play a role in treating inflammatory dermatosis. We hope to provide a new idea and theoretical basis for the treatment of specific dermatitis by studying the therapeutic effect of fluoxetine on atopic dermatitis and the mechanism of action for the treatment of atopic dermatitis. Methods first, we use 2,4- two nitrochlorobenzene (DNCB) acetone (DNCB) acetone solution to stimulate BALB/c mice. A mouse model of allergic dermatitis was used to study the effect of 5-HT reuptake inhibitor on atopic dermatitis and the molecular mechanism of its effect. The clinical efficacy of 5-HT reuptake inhibitor (Fu Xiting) on the clinical efficacy, SCORAD score, depression and anxiety of the mice with atopic dermatitis was elucidated in detail by the 5-HT reuptake inhibitors. The role of inhibitors in the treatment of atopic dermatitis; by detecting the skin thickness and mast cell number of mice with HE staining and toluidine blue staining in mice, the changes in the RNA level of the total Ig E of the spleen, the cytokine (IL-2, IL-4, IL-13, IFN-r) m RNA levels were detected in the mice, and the molecular machine for the treatment of atopic dermatitis by 5-HT reuptake inhibitors was explored. Results (1) fluoxetine could reduce the clinical symptoms of AD mice. (2) fluoxetine could significantly improve the depression and anxiety of AD mice. (3) fluoxetine inhibited the inflammatory response of the tissue and reduced the number of mast cells in the dermis of AD mice. (4) fluoxetine lowered the level of Ig E in the serum of AD mice (5) fluoxetine could reduce the I in the spleen of AD mice. L-4/IL-13 cytokine levels significantly reverse the imbalance in the expression of Th1 and Th2 cell related factors. Conclusion fluoxetine can improve the pruritus of AD. Fluoxetine can improve the immune imbalance by reducing IL-4/IL-13 and inhibiting the production of mast cells. Fluoxetine may improve the anxiety by inhibiting psychological stress and depression and thus improve AD..
【学位授予单位】:重庆医科大学
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R714.2
【相似文献】
相关期刊论文 前10条
1 蒙一纯,PhilipBrauer;早期鸡胚神经管和微核神经嵴的细胞凋亡[J];解剖科学进展;1997年03期
2 张建中;S—100蛋白在神经嵴起源组织及其肿瘤中的分布[J];实用癌症杂志;1988年02期
3 蔡良琬;神经组织发育与再生的研究进展[J];基础医学与临床;1994年06期
4 于蕾;倪洁丽;马俊青;陈文静;;Rap1b在斑马鱼神经嵴中表达情况的初探[J];口腔生物医学;2013年03期
5 Bahn CF ,王传富;以神经嵴起源为根据的角膜内皮疾病分类[J];眼科新进展;1986年02期
6 陆颖静;陈树宝;陆欧伦;;心脏神经嵴受损与心脏畸形发生的关系[J];中华儿科杂志;1997年01期
7 刘积才;谭义书;;神经嵴起源的少见肿瘤[J];肿瘤防治研究;1988年04期
8 张华;冯永;;PAX3基因对神经嵴发育的调控及其在Waardenburg综合征发病中的作用研究[J];听力学及言语疾病杂志;2014年02期
9 赵晓晴;心脏神经嵴发育与心脏锥干部畸形[J];国外医学(儿科学分册);2004年01期
10 刘向阳;王晔;宋维亚;张臻;;Wnt1-Cre标记心脏神经嵴来源细胞在房室瓣分布的实验研究[J];中华临床医师杂志(电子版);2012年22期
相关会议论文 前1条
1 蔺海燕;刘芳;张传森;张志英;孔征东;张喜;;移植了毛囊神经嵴干细胞源性神经元和施万细胞的神经移植体的体外特性[A];中国解剖学会2011年年会论文文摘汇编[C];2011年
相关博士学位论文 前3条
1 王晓钰;高糖环境诱导的过度自噬抑制鸡胚颅面部神经嵴产生[D];暨南大学;2015年
2 李彦希;曲马多引起胚胎发育缺陷的分子机制[D];重庆医科大学;2016年
3 行勇军;神经嵴来源外胚间充质干细胞在牙向分化中的潜能及相关机制的研究[D];第三军医大学;2016年
,本文编号:2161430
本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/2161430.html